RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Niederst, Matthew J., Sequist, Lecia V., Poirier, John T., Mermel, Craig H., Lockerman, Elizabeth L., Garcia, Angel R., Katayama, Ryohei, Costa, Carlotta +19 more·2015·Nature Communications

DOI 10.1038/ncomms7377

Cited by (655)

Items 301–400 of 655

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers
Anne Mc Leer, Matthieu Foll, Marie Brevet, Martine Antoine, Silvia Novello, Julie Mondet, Jacques L. Cadranel, Nicolas Girard, Matteo Giaj Levra, Pierre Demontrond et al. · 2022 · Lung Cancer
Advancing immunotherapy in small cell lung cancer
Jennifer Wilkinson Carlisle, Ticiana A.B. Leal · 2023 · Cancer
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B
Xiuning Le, Luis G Paz-Ares, Jan P. van Meerbeeck, Santiago Viteri, Carlos Cabrera Galvez, Egbert Frederik Smit, Marina Chiara Garassino, Rémi Veillon, David Vicente Baz, José Fuentes Pradera et al. · 2023 · Cell Reports Medicine
Acquired Resistance in Lung Cancer
Asmin Tulpule, Trever Grant Bivona · 2019 · Annual Review of Cancer Biology
Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review
Chen Shen, Yayi He, Juan Liu, Xiaoxia Chen, Jia Yu, Wei Li, Bin Chen, Chenglong Sun, Caicun Zhou · 2019 · OncoTargets and Therapy
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
Chih-An Lin, Sung‐Liang Yu, Hsuan‐Yu Chen, Huei‐Wen Chen, Shr-Uen Lin, Chia‐Ching Chang, Chong‐Jen Yu, Pan‐Chyr Yang, Chao‐Chi Ho · 2018 · Journal of Thoracic Oncology
YAP1 and PRDM14 converge to promote cell survival and tumorigenesis
Mi‐Ju Kim, Seav Huong Ly, Yingtian Xie, Gina N. Duronio, Dane Ford-Roshon, Justin H. Hwang, Rita Sulahian, Jonathan P. Rennhack, Jonathan So, Ole V. Gjoerup et al. · 2022 · Developmental Cell
Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
Julio César Osorio, Rancés Blanco, Alejandro H. Corvalán, Juan Pablo Muñoz, Gloria M. Calaf, Francisco Aguayo · 2022 · Pathogens
Cancer as a Disease of Development Gone Awry
Ben Z. Stanger, Geoffrey M. Wahl · 2023 · Annual Review of Pathology Mechanisms of Disease
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W. Whitfield, Asaf Maoz, Sarah Reeves, José Velarde, Dian Yang, Anna Meglan, Juliano Ribeiro, Jasmine Blandin et al. · 2024 · Journal of Clinical Investigation
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR -mutant lung cancer
Pınar Ö. Eser, Raymond M. Paranal, Jieun Son, Elena V. Ivanova, Yanan Kuang, Heidi M. Haikala, Ciric To, Jeffrey J. Okoro, Kshiti H. Dholakia, Jihyun Choi et al. · 2021 · Science Translational Medicine
Toppling high-grade pulmonary neuroendocrine tumors with a DLL3-targeted trojan horse
Scott J. Dylla · 2016 · Molecular & Cellular Oncology
Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Lillian M. Perez, Smrruthi Vaidegi Venugopal, Anna St Martin, Stephen J. Freedland, Dolores Di Vizio, Michael R. Freeman · 2024 · Trends in cancer
Molecular Characterization and Therapeutic Approaches to Small Cell Lung Cancer: Imaging Implications
Hyesun Park, Shu-Chi Tseng, Lynette Marie Sholl, Hiroto Hatabu, Mark Magdi Awad, Mizuki Nishino · 2022 · Radiology
Transformation of NSCLC to SCLC harboring EML4–ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review
Lingling Xu, Chen Maoxi, Wei Ye, Zhao Jieting, Yao Yuanyuan, Ning Xu · 2023 · Lung Cancer
Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies
Susumu Kohno, Shunsuke Kitajima, Nobunari Sasaki, Chiaki Takahashi · 2016 · World Journal of Stem Cells
Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance
Tongyan Liu, Chencheng Han, Panqi Fang, Hongyu Zhu, Siwei Wang, Zhifei Ma, Quanli Zhang, Wenjia Xia, Jie Wang, Lin Xu et al. · 2020 · Cellular and Molecular Life Sciences
Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling
Wei Wang, Xinhang Xia, Kuifei Chen, Chen Meng, Yinnan Meng, Dongqing Lv, Haihua Yang · 2021 · Frontiers in Oncology
Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models
Sun Min Lim, San-Duk Yang, Sangbin Lim, Seong Gu Heo, Daniel Stetson, Aleksandra A. Markovets, Rafati Minoo, Kyoung‐Ho Pyo, Mi Ran Yun, Min Hee Hong et al. · 2022 · Therapeutic Advances in Medical Oncology
Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
Yi Shao, Diansheng Zhong · 2017 · International Journal of Clinical Oncology
Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation
Shian‐Ren Lin, Hsiu‐Lien Yeh, Yen‐Nien Liu · 2021 · Cancers
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
Michele Simbolo, Giovanni Centonze, Greta Alì, Giovanna Garzone, Sergio Vincenzo Taormina, Giovanna Sabella, Chiara Ciaparrone, Andrea Mafficini, Federica Grillo, Alessandro Mangogna et al. · 2021 · ESMO Open
PRIM2 Promotes Cell Cycle and Tumor Progression in p53-Mutant Lung Cancer
Taoyuan Wang, Tiansheng Tang, Youguo Jiang, Tao He, Luyu Qi, Hongkai Chang, Yaya Qiao, Mingming Sun, Changliang Shan, Xinyuan Zhu et al. · 2022 · Cancers
Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer
Jiyun Lee, Zofia Piotrowska, Ross Andrew Soo, Byoung Chul Cho, Sun Min Lim · 2022 · Therapeutic Advances in Medical Oncology
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications
Gouji Toyokawa, Francesca Bersani, Paolo Bironzo, Francesca Picca, Fabrizio Tabbò, Naoki Haratake, Tomoyoshi Takenaka, Takashi Seto, Tomoharu Yoshizumi, Silvia Novello et al. · 2023 · Critical Reviews in Oncology/Hematology
Transcriptomic Heterogeneity of EGFR -Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
Songji Oh, Jaemoon Koh, Tae Min Kim, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Ja‐Lok Ku, Dong‐Wan Kim et al. · 2024 · Clinical Cancer Research
Understanding serine and glycine metabolism in cancer: a path towards precision medicine to improve patient’s outcomes
Anaís Sánchez‐Castillo, Kim Rosalie Kampen · 2024 · Discover Oncology
Nanoformulated Paclitaxel and AZD9291 Synergistically Eradicate non-small-cell Lung Cancers In Vivo
Xin-shuai Wang, Li Zhang, Xiaocen Li, De-jiu Kong, Xiao-chen Hu, Xue-zhen Ding, Jun-qiang Yang, Meng-qi Zhao, Yixuan He, Kit S. Lam et al. · 2018 · Nanomedicine
Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib
Xiaohui Ren, Xinfeng Cai, Jing Li, Xia Zhang, Jianfei Yu, Xin Song, Henghui Zhang, Xia Song · 2020 · Journal of International Medical Research
Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report
Liying Fang, Jian He, Jingwen Xia, Liang Dong, Xiujuan Zhang, Yaqin Chai, Ying Li, Mengjie Niu, Tianxing Hang, Shengqing Li · 2017 · Oncology Letters
Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR‐mutated lung adenocarcinoma: a report of two cases
Hironori Uruga, Takeshi Fujii, Nobuyuki Nakamura, Shuhei Moriguchi, Kazuma Kishi, Hisashi Takaya · 2020 · Respirology Case Reports
Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon
Xiao Chu, Yuyin Xu, Li Ye, Yue Zhou, Li Chu, Xi Yang, Jianjiao Ni, Yida Li, Tiantian Guo, Zhiqin Zheng et al. · 2022 · Lung Cancer
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression
Misha C. Tran, Garth William Strohbehn, Theodore G Karrison, Sherin Juliet Rouhani, Jeremy P. Segal, Ardaman P. Shergill, Philip C. Hoffman, Jyoti D. Patel, Marina Chiara Garassino, Everett E. Vokes et al. · 2023 · Clinical Lung Cancer
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine
Martin Sattler, Isa Mambetsariev, Jeremy Fricke, Tingting Tan, Sariah Liu, Nagarajan Vaidehi, Evan P. Pisick, Tamara Mirzapoiazova, Adam Rock, Amartej Merla et al. · 2023 · Journal of Clinical Medicine
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
Samuel K. McBrayer, Benjamin A. Olenchock, Gabriel J. DiNatale, Diana D. Shi, Januka Khanal, Rebecca B. Jennings, Jesse S. S. Novak, Matthew G. Oser, Alissa K. Robbins, Rebecca Modiste et al. · 2018 · Proceedings of the National Academy of Sciences
Histologic transformation of non-small-cell lung cancer in brain metastases
Meng Jiang, Xiaolong Zhu, Xiao Han, Haiyan Jing, Tao Han, Qiang Li, Xiao Ding · 2018 · International Journal of Clinical Oncology
Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells
Yuki Tenjin, Kazuyoshi Nakamura, Shiho Ishizuka, Koichi Saruwatari, Ryo Sato, Yusuke Tomita, Sho Saeki, Hidenori Ichiyasu, Kazuhiko Fujii, Takaaki Ito et al. · 2019 · Internal Medicine
Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes
Blas A. Guigni, Jos L. J. van der Velden, C. Matthew Kinsey, James A. Carson, Michael J. Toth · 2019 · American Journal of Physiology-Endocrinology and Metabolism
Resistance to First-line Osimertinib in EGFR-mutant NSCLC: Tissue is the Issue
Zofia Piotrowska, Aaron N. Hata · 2020 · Clinical Cancer Research
Overexpression of CD 133 and BCL‐2 in non‐small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement‐positive adenocarcinoma
KIYOKO KOYAMA, Naoko Katsurada, Naoe Jimbo, Motoko Yoshikawa TACHIHARA, Daisuke Tamura, Kyosuke Nakata, Tatsuya Nagano, Masatsugu Yamamoto, Hiroshi Kamiryo, Kazuyuki Kobayashi et al. · 2019 · Pathology International
Persistent lineage plasticity driving lung cancer development and progression
Fanchen Meng, J. Li, Zhijun Xia, Qinglin Wang, Qinhong Sun, Siwei Wang, Lin Xu, Rong H. Yin · 2025 · Clinical and Translational Medicine
Lung cancer as a paradigm for precision oncology in solid tumours
Simon Schallenberg, Sabine Merkelbach‐Bruse, Reinhard Buettner · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Emerging drugs for EGFR-mutated non-small cell lung cancer
Vineeth Sukrithan, Lei Deng, Alexander Barbaro, Haiying Cheng · 2018 · Expert Opinion on Emerging Drugs
REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma
Meitetsu Masawa, Hanako Sato‐Yazawa, Korehito Kashiwagi, Jun Ishii, Chie Miyata-Hiramatsu, M. Iwamoto, Kakeru Kohno, Tadasuke Miyazawa, Masato Onozaki, Shuhei Noda et al. · 2022 · American Journal Of Pathology
Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
Barbara Rath, Adelina Plangger, Gerhard Hamilton · 2020 · Cancer Drug Resistance
High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib
Atsushi Osoegawa, Masafumi Yamaguchi, Tomomi Nakamura, Ryotaro Morinaga, Kentaro Tanaka, Kosuke Kashiwabara, Takashi Miura, Takayuki Suetsugu, Taishi Harada, Tatsuma Asoh et al. · 2021 · JTO Clinical and Research Reports
An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression
Debjani Pal, Polona Šafarič Tepeš, Trine Lindsted, Ingrid Ibarra, Amaia Lujambio, Vilma Jiménez Sabinina, Şerif Şentürk, Madison A. Miller, Navya Korimerla, Jiahao Huang et al. · 2021 · eLife
Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Yongsheng Wang, Feng Jiang, Ruixue Xia, Ming Li, Chengyun Yao, Yan Li, Hui Li, Qi Zhao, Mingke Shi, Yanzhe Yu et al. · 2021 · Frontiers in Oncology
Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer
Jinping Wang, Jiping Yan, Jing Xu, Tinghui Yin, Rongqin Zheng, Wei Wang · 2019 · Cancer Management and Research
Transformation from EGFR-mutant lung adenocarcinoma to small-cell lung cancer: from clonal evolution to lineage reprogramming
Haoxin Wang, Nan Gao, Lu Wang, Feiran Yang, Bin Liu, Xiwen Hu, Yufeng Zhao, Rui Sha, Xiurong Li, Huijie Li · 2025 · Cancer Treatment Reviews
Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma
Shuye Lin, Cuimeng Tian, Jianhui Li, Bin Liu, Teng Ma, Keqiang Chen, Wanghua Gong, Ji Wang, Jiaqiang Huang · 2021 · Oncology Reports
Histologic Changes in Non–Small Cell Lung Cancer under Various Treatments: A Comparison of Histology and Mutation Status in Serial Samples
Chang Gok Woo, Seung-Myoung Son, Ho‐Chang Lee, Hye Sook Han, Ki Hyeong Lee, Dohun Kim, Eung‐Gook Kim, Ok-Jun Lee · 2021 · Cancer Research and Treatment
Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma
Xiaowei Mao, Jiabing Liu, Fang Hu, Yanjie Niu, Feng Pan, Xiaolong Fu, Liyan Jiang · 2022 · Cancer Management and Research
Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases
Hao Liu, Lihong Chen, Zhihui Zhang, Ning Wang, Si-Hui Zhuang, Hao Chen, Jin Tong Du, Lijuan Pang, Yan Qi · 2022 · Frontiers in Oncology
Molecular mechanisms of therapy resistance in solid tumors: chasing “moving” targets
Laura J. Tafe · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Case report: HER2 amplification as a resistance mechanism to crizotinib in NSCLC with MET exon 14 skipping
Guanggui Ding, Jian Wang, Peikun Ding, Yuxin Wen, Lin Yang · 2019 · Cancer Biology & Therapy
Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
Paola Indovina, Francesca Pentimalli, Daniele Conti, Antonio Giordano · 2019 · Biochemical Pharmacology
Low T790M relative allele frequency indicates concurrent resistance mechanisms and poor responsiveness to osimertinib
Ye Wang, Yanqi He, Panwen Tian, Weiya Wang, Ke Wang, Shannon Chuai, Yalun Li, Shuang Zhao, Yu Wang, Weimin Li · 2020 · Translational Lung Cancer Research
Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC
Xinlin Liang, Anqi Lin, Qiongyao Wang, Jian Zhang, Peng Luo · 2022 · Biomedicine & Pharmacotherapy
RB1 loss induced small cell lung cancer transformation as acquired resistance to pembrolizumab in an advanced NSCLC patient
Sayaka Arakawa, Tatsuya Yoshida, Masayuki Shirasawa, Daisuke Takayanagi, Shigehiro Yagishita, Noriko Motoi, Yuichiro Ohe · 2020 · Lung Cancer
Whole-Process Treatment of Combined Small Cell Lung Cancer Initially Diagnosed as “Lung Squamous Cell Carcinoma”: A Case Report and Review of the Literature
Yong Quan Dong, Qijun Li, Da Li, Yong Fang, Chongwei Wang · 2022 · Frontiers in Immunology
Histological transformation in lung cancer: Mechanisms, clinical characteristics, and therapeutic approaches
Shiyi Liu, Xu Tao, Xiaojing Cao, Hecheng Li, Runsen Jin · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The epigenome and the many facets of cancer drug tolerance
Paul C. Moore, Kurt W. Henderson, Marie Classon · 2023 · Advances in cancer research
Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review
Catherine Belle Meador, Zofia Piotrowska · 2023 · Translational Lung Cancer Research
Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer
Aiguang Wang, Cuiping Han, Hui Zhao, Zhaomin Zheng, Xin Ye, Rong Shan · 2023 · Journal of Cancer Research and Therapeutics
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets
Jun Jiang, Donghui Han, Jiawei Wang, Weihong Wen, Rui Zhang, Weijun Qin · 2024 · MedComm
Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
Rama Soundararajan, Ana M. Aparicio, Christopher J. Logothetis, Sendurai A. Mani, Sankar N. Maity · 2018 · Frontiers in Oncology
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Martin Michaelis, Yvonne Voges, Florian Rothweiler, Fabian Weipert, Amara Zia-Ahmad, Jaroslav Činátl, Andreas von Deimling, Frank Westermann, Franz Rödel, Mark N. Wass et al. · 2020 · Cancers
Non-small-cell lung cancer: how to manage EGFR-mutated disease
Federica Pecci, Luca Cantini, Giulio Metro, Biagio Ricciuti, Giuseppe Lamberti, Ammad Ahmad Farooqı, Rossana Berardi · 2022 · Drugs in Context
Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms
Claudia Proto, Giuseppe Lo Russo, Giulia Corrao, Monica Ganzinelli, Francesco Facchinetti, Roberta Minari, Marcello Tiseo, Marina Chiara Garassino · 2017 · Tumori Journal
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck
Gabrielle van Caloen, Sandra Schmitz, Cédric van Marcke, Xavier Caignet, Antonella Mendola, Sébastien Pyr dit Ruys, Pierre P. Roger, Didier Vertommen, Jean‐Pascal Machiels · 2021 · Cancers
Large Cell Neuroendocrine Carcinoma Transformation as a Mechanism of Acquired Resistance to Osimertinib in Non-small Cell Lung Cancer: Case Report and Literature Review
Matthew H. Lee, Dhruv G. Patel, Sebastian A. Jofre, Shabnam A. Fidvi, Mark J. Suhrland, Perry R. Cohen, Haiying Cheng · 2021 · Clinical Lung Cancer
Unlocking the Mystery of Small-Cell Lung Cancer Transformations in EGFR Mutant Adenocarcinoma
Anna F. Farago, Zofia Piotrowska, Lecia Van Dam Sequist · 2017 · Journal of Clinical Oncology
Identifying a missing lineage driver in a subset of lung neuroendocrine tumors
Karine Pozo, John Dorrance Minna, Jane E. B. Johnson · 2018 · Genes & Development
Histologically Transformed SCLC From EGFR-Mutant NSCLC: Understanding the Wolf in Sheep’s Clothing
Sanjay Popat · 2019 · Journal of Thoracic Oncology
Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report
Meng‐Hang Yang, Jia Yu, Chen-Lei Cai, Wěi Li · 2022 · Frontiers in Oncology
Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
Shiling Zhang, Chanyuan Zhang, Yuqing Chen, Yufa Li, Zhi Xie, Xuchao Zhang, Qing Hua Zhou, Wen‐Zhao Zhong, Jie Huang, Hao Xuan Sun et al. · 2023 · Journal of Thoracic Disease
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators
Francesco Volta, Silvia La Monica, Alessandro Leonetti, Letizia Gnetti, Mara A. Bonelli, Andrea Cavazzoni, Claudia Fumarola, Maricla Galetti, Kamal Eltayeb, Roberta Minari et al. · 2023 · Targeted Oncology
Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix
Masamune Masuda, Keita Iida, Sadahiro Iwabuchi, Mie Tanaka, Satoshi Kubota, Hiroyuki Uematsu, Kunishige Onuma, Yoji Kukita, Kikuya Kato, Shoji Kamiura et al. · 2023 · American Journal Of Pathology
IGFBP7 overexpression promotes acquired resistance to AZD9291 in non-small cell lung cancer
Xiaonan Tang, Jing Mu, Li Ma, Qifan Tan, Jinghui Wang, Jinjing Tan, Shucai Zhang · 2021 · Biochemical and Biophysical Research Communications
Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas
Jia Zhong, Xiaoting Li, Zhijie Wang, Jianchun Duan, Wenbin Li, Minglei Zhuo, Tongtong An, Ziping Wang, Tiantian Gu, Yuyan Wang et al. · 2021 · Journal of the National Cancer Center
Loss of the retinoblastoma tumor suppressor correlates with improved outcome in patients with lung adenocarcinoma treated with surgery and chemotherapy
Matthew J. Cecchini, Charles A. Ishak, Daniel T. Passos, Andrew Warner, David A. Palma, Christopher J. Howlett, David K. Driman, Frederick A. Dick · 2015 · Human Pathology
Genomic architecture of lung cancers
Lynnette Fernandez‐Cuesta, James McKay · 2015 · Current Opinion in Oncology
Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer Drugs
Manjula Vinayak · 2018 · Nutrition and Cancer
Transformation of epidermal growth factor receptor T790M mutation‐positive adenosquamous carcinoma of the lung to small cell carcinoma and large‐cell neuroendocrine carcinoma following osimertinib therapy: an autopsy case report
Shuhei Moriguchi, Hironori Uruga, Takeshi Fujii, Yoichi Yasunaga, Yui Takahashi, Kazuma Kishi · 2019 · Respirology Case Reports
The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment
Naoko Sueoka‐Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda et al. · 2021 · Cancer Medicine
A case of resistance to tyrosine kinase inhibitor therapy
Yanjun Xu, Zhiyu Huang, Lei Gong, Yun Fan · 2017 · Anti-Cancer Drugs
Transformation to small‑cell lung cancer following treatment with icotinib in a patient with lung adenocarcinoma
Hongyang Lu, Bo Chen, Jing Qin, Fajun Xie, Na Han, Zhiyu Huang · 2018 · Oncology Letters
Robust foreground detection in somatic copy number data
Aditya S. Deshpande, Trent J. Walradt, Ya Hu, Amnon Koren, Marcin B. Imielinski · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Contribution of Microhomology to Genome Instability: Connection between DNA Repair and Replication Stress
Yuning Jiang · 2022 · International Journal of Molecular Sciences
Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and Responses to Targeted Therapies
Sarah Waliany, Yin Pun Hung, Fawzi Abu Rous, Faustine Luo, Marzia Capelletti, Steven J. Ressler, Andrew Do, Jennifer Peterson, Caitlin Meservey, Subba Rao Digumarthy et al. · 2025 · Clinical Lung Cancer
Pseudo-small cell transformation in EGFR-mutant adenocarcinoma
Rui Li, Lili Jiang, Xiaojuan Zhou, You Lü, Yan Zhang · 2021 · Lung Cancer
Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
Sarang S. Talwelkar, Mikko Ilari Mäyränpää, Lars Søraas, Swapnil Potdar, Jie Bao, Annabrita Hemmes, Nora Linnavirta, Jon Lømo, Jari Veli Räsänen, Aija Knuuttila et al. · 2021 · Cell Reports Medicine
Lung stem cells in regeneration and tumorigenesis
Yuting Chen, Yun Xue, Yujuan Jin, Hongbin Ji · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report
Sho Takuma, Yusuke Inoue, Masato Karayama, Kazuo Tsuchiya, Hiroe Tsukui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa et al. · 2021 · JTO Clinical and Research Reports
Genomic features of Chinese small cell lung cancer
Jun Liu, Zhuxiang Zhao, Shuquan Wei, Binkai Li, Ziwen Zhao · 2022 · BMC Medical Genomics
Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution
Jaime Laurel Schneider, Khvaramze Shaverdashvili, Mari A. Mino-Kenudson, Subba Rao Digumarthy, Andrew Do, Audrey Liu, Justin F. Gainor, Jochen K. Lennerz, Timothy Francis Burns, Jessica J. Lin · 2023 · npj Precision Oncology
The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy
Janaki Neela Sharma, Elaine Shum, Vincent Chau, Daniel Paucar, Haiying Cheng, Balázs Halmos · 2016 · Respiration
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer–Transformed EGFR Mutant Non–Small-Cell Lung Cancer
Meghan J. Mooradian, Zofia Piotrowska, Benjamin Jacob Drapkin, Dora C. Dias-Santagata, Nicolas Marcoux, Konstantinos Arnaoutakis, Rebecca J. Nagy, Richard Burnham Lanman, Anthony John Iafrate, Anna F. Farago et al. · 2017 · JCO Precision Oncology
Transformation to small cell lung cancer after first-line afatinib treatment
Takayuki Shiroyama, Shingo Nasu, Ayako Tanaka, So Takata, Kentaro Masuhiro, Hiromune Takada, Satomu Morita, Naoko Morishita, Hidekazu Suzuki, Norio Okamoto et al. · 2018 · Respiratory Medicine Case Reports